Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2011-08-23
2011-08-23
Monshipouri, Maryam (Department: 1656)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C536S023100, C435S320100
Reexamination Certificate
active
08003345
ABSTRACT:
The invention relates to a pharmaceutical compound for antioxidant protection of cells, tissues and entire organism against hyperproduction of fee radicals. The inventive compound comprises an effective quantity of at least one antioxidant in the form of a main acting component. Said antioxidant is selected from a group consisting peroxiredoxine, a fragment thereof, dihydrolipoic acid and the combinations thereof with acceptable pharmaceutical additives. The inventive method for preventing and curing mammals consists in contacting the effective quantity of the compound with intercellular space of tissue, organ and entire mammal organism. Low toxicity of the compound makes it possible to increase the efficiency of treatment of multifactor actions on an organism, for example radiation, thermal, chemical burn, wounds and hurts as a result of disasters and fires.
REFERENCES:
patent: 2002/0168353 (2002-11-01), Lynn et al.
patent: 2003/0124137 (2003-07-01), Dalton et al.
patent: 2003/0186839 (2003-10-01), Awaya et al.
patent: 2007/0042425 (2007-02-01), Hochstrasser et al.
patent: 2007/0196844 (2007-08-01), Pestlin et al.
patent: 2007/0292406 (2007-12-01), Kang et al.
patent: 1394182 (2004-03-01), None
patent: 2798672 (2001-03-01), None
patent: 2008275413 (2008-11-01), None
patent: 20050046916 (2005-05-01), None
patent: 20050052754 (2005-06-01), None
patent: 20060020140 (2006-03-01), None
patent: 2250262 (2005-03-01), None
patent: 2280448 (2006-07-01), None
patent: 98/43666 (1998-08-01), None
patent: 2007/140976 (2007-12-01), None
patent: 2008/036835 (2008-03-01), None
Fujii et al. “Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role,” Eur. J. Biochem., vol. 268, pp. 218-224, 2001.
Kang et al. “Characterization of a Mammalian Peroxiredoxin that contains one conserved Cysteine,” The J. of Biol. Chem., vol. 273, No. 11, pp. 6303-6311, Mar. 13, 1998.
Kang et al. “Peroxiredoxin-6, 1-Cys peroxiredoxin,” SEQ ID No. 2 alignment result 1, Accession No. PRDX6—HUMAN, Database: UniProt—8.4.
SEQ ID No. 2 alignment result 10, Accession No. PRDX6—MOUSE, Database: UniProt—8.4.
Espacenet English Abstract of FR 2798672 B1, 2003.
Espacenet English Abstract of JP 2008275413 A, 2008.
Kumin A. et al. Peroxiredoxin 6 is a Potent Cytoprotective Enzyme in the Epidermis. The American Journal of Pathology, vol. 169, No. 4, Oct. 2006, 1194-1205.
A. Nekrasov et all The Novel Approach to the Protein Design: Active Truncated Forms of Human 1-CYS Peroxiredoxin. J. of Biomolec. Structure & Dynamics, V.24 No. 5 (2007). http//www.jbsdonline.com.
Trudel S. et al. Peroxiredoxin 6 Fails to Limit Phospholipid Peroxidation in Lung from C/Tr-Knockout Mice Subjected to Oxidative Challenge. Jun. 29, 2009. (http://www.plosone.Org/article/info:doi%2F10.1371 %2Fiournal.pone.0006075).
Espacenet Bibliographic data of KR 20060020140 A, 2006.
Espacenet Bibliographic data of KR 20050046916 A, 2005.
Espacenet English Abstract of KR 20010083976 A, 2001.
Espacenet English Abstract of RU 2250262, 2005.
W. Lee et al. Human Peroxiredoxin 1 and 2 Are Not Duplicate Proteins: The Unique Presence of CYS83 in Prx1 Underscores the Structural and Functional Differences Between Prx1 and Prx2 J. Biol. Chem. 2007.
Fesenko Evgeny Evgenyevich
Lipkin Valery Mikhaylovich
Novoselov Vladimir Ivanovich
Shuvaeva Tatyana Maratovna
Yanin Vadim Alekseevich
Institute of Cell Biophysics Russian Academy of Sciences
Ladas & Parry LLP
Monshipouri Maryam
LandOfFree
Antioxidant pharmaceutical compound, method for producing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antioxidant pharmaceutical compound, method for producing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antioxidant pharmaceutical compound, method for producing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2724621